HUTCHMED (China) Limited
HCM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £1 | £1 | £0 | £0 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Cost of Goods Sold | £0 | £1 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 44.6% | 18.1% | 27% | 27.5% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | -£0 | -£0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £1 | £0 |
| Operating Income | -£0 | £0 | -£0 | -£0 |
| % Margin | -6.4% | 2.2% | -95.6% | -92.2% |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | £0 | £0 | -£0 | -£0 |
| Tax Expense | £0 | £0 | -£0 | £0 |
| Net Income | £0 | £0 | -£0 | -£0 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS | 0.044 | 0.12 | -0.43 | -0.25 |
| % Growth | -63.4% | 127.9% | -72% | – |
| EPS Diluted | 0.043 | 0.12 | -0.43 | -0.25 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £0 | £0 | -£0 | -£0 |
| % Margin | 2.2% | 8% | -94.1% | -90.2% |